Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Active not recruiting 2Enrolling by invitation 1

Sponsor Class

OTHER 3

Study Type

Observational 2Interventional 1

Sponsor

Cancer Type

Gastrointestinal 3

Conditions

Colonic Neoplasms 3Postoperative Complications 1Ileus 1Colorectal Neoplasms 1Carcinoma, Hepatocellular 1Anastomotic Leak 1

Interventions

Oxaliplatin 297Fluorouracil 272Bevacizumab 235Gemcitabine 234Leucovorin 212Capecitabine 204pembrolizumab 200Nivolumab 157Irinotecan 156Cisplatin 148Specimen Handling 143Magnetic Resonance Spectroscopy 130130-nm albumin-bound paclitaxel 115Paclitaxel 109durvalumab 104Cetuximab 102Radiotherapy 96atezolizumab 92Biopsy 92Drug Therapy 91Albumin-Bound Paclitaxel 78tislelizumab 77Taxes 73Folfox protocol 68lenvatinib 67Carboplatin 65regorafenib 60Blood Specimen Collection 60trifluridine tipiracil drug combination 52Ipilimumab 52

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Colectomy × Gastrointestinal × 1 year × Clear all
NCT07289568 2025-12-17

SPARROW

Acibadem University

Enrolling by invitation
140 enrolled
Gastrointestinal

Colonic Neoplasms, Postoperative Complications, Colorectal Neoplasms, Ileus, Anastomotic Leak

NCT03432806 2025-12-02

A Study of Imaging, Blood, and Tissue Samples to Guide Treatment of Colon Cancer and Related Liver Tumors

Memorial Sloan Kettering Cancer Center

Active not recruiting
51 enrolled
Gastrointestinal

Colonic Neoplasms, Carcinoma, Hepatocellular

NCT06124378 2025-09-24

Neoadjuvant Tislelizumab With Chemotherapy for the Treatment of MSS Colon Cancer

First Affiliated Hospital of Guangxi Medical University

Phase 2 Active not recruiting
60 enrolled
Gastrointestinal

Colonic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡